We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,300

Mayo on the side? The Canadian Patent Office issues new examination guidelines for medical diagnostic methods
  • Borden Ladner Gervais LLP
  • Canada
  • July 17 2015

On June 29, 2015, the Canadian Intellectual Property Office (CIPO) issued a long-awaited Practice Notice PN 2015-02("Notice") on the subject of


Rx IP update 2015 mid-year highlights
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • July 16 2015

The following is a mid-year review of the top IP and regulatory law developments in life sciences in Canada. 1. Still no clarification from Supreme


Court of Appeal gives guidance on sound prediction issues
  • Borden Ladner Gervais LLP
  • Canada
  • July 15 2015

The Federal Court of Appeal (FCA) upheld a recent infringement decision finding a patent to be invalid due to inutility (decision here; summary here


Federal Court of Appeal reinterprets product specificity requirements: patent listing is determined by patent claims construction and not a word match
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 23 2015

On July 17, 2015, the Federal Court of Appeal set aside a judgment of the Federal Court that upheld Health Canada’s refusal to list Canadian Patent 2


First class action involving a prescription drug being denied certification in British Columbia?
  • McCarthy Tétrault LLP
  • Canada
  • July 16 2015

In Charlton v. Abbott Laboratories, Ltd., 2015 BCCA 26, the Court of Appeal for British Columbia overturned certification of a class action on behalf


Court of Appeal’s decision on assessments by someone other than a health practitioner
  • Torkin Manes LLP
  • Canada
  • July 24 2015

Does the Court have jurisdiction to Order a party to undergo an assessment by someone who is not a "health practitioner"? The Court of Appeal says


Federal court grants interlocutory stay in IP dispute
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 8 2015

On June 12, 2015, the Federal Court issued an interlocutory stay in the context of a data protection application in Horizon Pharma plc v The Minister


Supreme Court raises bar for leave to bring secondary market securities class actions
  • Dentons
  • Canada
  • July 14 2015

In Theratechnologies Inc v 12185 Canada Inc, the Supreme Court of Canada ruled that Section 225(4) of the Quebec Securities Act which, as a


Pharma in brief - Apotex Inc. and Apotex Pharmachem Inc. are ordered to disgorge profits in excess of $61 million
  • Norton Rose Fulbright Canada LLP
  • Canada
  • July 10 2015

Apotex Inc. (Apotex) and Apotex Pharmachem Inc. (Pharmachem) have been ordered by the Federal Court to pay to Adir and Servier Canada


Canadian privacy class action and PHIPA prosecution developments
  • Osler Hoskin & Harcourt LLP
  • Canada
  • July 10 2015

In Condon v. Canada, the Federal Court of Appeal has ruled that negligence and breach of confidence should be included in the nature of the claims